Cargando…

Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose

Direct oral anticoagulants (DOACs) have been used more frequently for the prevention and management of thromboembolic disease in comparison to their predecessors. DOACs provide greater ease of administration, shorter half-lives, less monitoring, and fewer drug-drug interactions. With the rise of DOA...

Descripción completa

Detalles Bibliográficos
Autores principales: Casey, Bradley, Daniels, Abigail, Bahekar, Amol, Patel, Divyang, Chapa-Rodriguez, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939290/
https://www.ncbi.nlm.nih.gov/pubmed/36814751
http://dx.doi.org/10.7759/cureus.34019
_version_ 1784890813763813376
author Casey, Bradley
Daniels, Abigail
Bahekar, Amol
Patel, Divyang
Chapa-Rodriguez, Alejandro
author_facet Casey, Bradley
Daniels, Abigail
Bahekar, Amol
Patel, Divyang
Chapa-Rodriguez, Alejandro
author_sort Casey, Bradley
collection PubMed
description Direct oral anticoagulants (DOACs) have been used more frequently for the prevention and management of thromboembolic disease in comparison to their predecessors. DOACs provide greater ease of administration, shorter half-lives, less monitoring, and fewer drug-drug interactions. With the rise of DOACs such as rivaroxaban, the opportunity for abuse also increases. Therefore, standardization of care based on rivaroxaban misuse must also be explored, an area in which there is not ample information. We present a case where a patient consumed a stockpile of her home medications in hopes to commit suicide. A 64-year-old female presented to the emergency department due to the ingestion of rivaroxaban 5,000 mg along with ingestion of acetaminophen 30,000 mg and isosorbide mononitrate 1000 mg in the setting of intentional self-harm with multiple declarations of being classified as Do Not Resuscitate. There have been documented cases of rivaroxaban overdose, however, there are no documented cases with levels of ingestion reaching 5,000 mg along with signs of severe bleeding. Our case study reviews the previously documented management of rivaroxaban abuse and the treatment that was given to our patient in the setting of extreme anticoagulant ingestion.
format Online
Article
Text
id pubmed-9939290
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-99392902023-02-21 Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose Casey, Bradley Daniels, Abigail Bahekar, Amol Patel, Divyang Chapa-Rodriguez, Alejandro Cureus Cardiology Direct oral anticoagulants (DOACs) have been used more frequently for the prevention and management of thromboembolic disease in comparison to their predecessors. DOACs provide greater ease of administration, shorter half-lives, less monitoring, and fewer drug-drug interactions. With the rise of DOACs such as rivaroxaban, the opportunity for abuse also increases. Therefore, standardization of care based on rivaroxaban misuse must also be explored, an area in which there is not ample information. We present a case where a patient consumed a stockpile of her home medications in hopes to commit suicide. A 64-year-old female presented to the emergency department due to the ingestion of rivaroxaban 5,000 mg along with ingestion of acetaminophen 30,000 mg and isosorbide mononitrate 1000 mg in the setting of intentional self-harm with multiple declarations of being classified as Do Not Resuscitate. There have been documented cases of rivaroxaban overdose, however, there are no documented cases with levels of ingestion reaching 5,000 mg along with signs of severe bleeding. Our case study reviews the previously documented management of rivaroxaban abuse and the treatment that was given to our patient in the setting of extreme anticoagulant ingestion. Cureus 2023-01-20 /pmc/articles/PMC9939290/ /pubmed/36814751 http://dx.doi.org/10.7759/cureus.34019 Text en Copyright © 2023, Casey et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Casey, Bradley
Daniels, Abigail
Bahekar, Amol
Patel, Divyang
Chapa-Rodriguez, Alejandro
Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose
title Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose
title_full Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose
title_fullStr Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose
title_full_unstemmed Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose
title_short Management of Massive Rivaroxaban Overdose With Acetaminophen and Isosorbide Mononitrate Overdose
title_sort management of massive rivaroxaban overdose with acetaminophen and isosorbide mononitrate overdose
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939290/
https://www.ncbi.nlm.nih.gov/pubmed/36814751
http://dx.doi.org/10.7759/cureus.34019
work_keys_str_mv AT caseybradley managementofmassiverivaroxabanoverdosewithacetaminophenandisosorbidemononitrateoverdose
AT danielsabigail managementofmassiverivaroxabanoverdosewithacetaminophenandisosorbidemononitrateoverdose
AT bahekaramol managementofmassiverivaroxabanoverdosewithacetaminophenandisosorbidemononitrateoverdose
AT pateldivyang managementofmassiverivaroxabanoverdosewithacetaminophenandisosorbidemononitrateoverdose
AT chaparodriguezalejandro managementofmassiverivaroxabanoverdosewithacetaminophenandisosorbidemononitrateoverdose